TITLE

FIVE THINGS TO KNOW ABOUT... The use of opioids for dyspnea in advanced disease

AUTHOR(S)
Gallagher, Romayne
PUB. DATE
July 2011
SOURCE
CMAJ: Canadian Medical Association Journal;7/12/2011, Vol. 183 Issue 10, p1170
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information about the use of opioids in treating dyspnea in advanced disease. It states that opioids are highly used for treating dyspnea refractory to disease-specific therapy in advanced disease. It notes that opiods with active metabolites can accumulate in frail older patients which can cause drowsiness, confusion, and delirium.
ACCESSION #
64572463

 

Related Articles

  • Managing Dyspnea in Patients at the End of Life. Sadovsky, Richard // American Family Physician;7/1/2002, Vol. 66 Issue 1, p152 

    Discusses ways to manage dyspnea, a feeling of being unable to catch one's breath. Potential causes of dyspnea; Symptomatic therapies; Details on opioid dosing for relief of dyspnea.

  • Opioids for dyspnoea. Muers, M.F. // Thorax;Nov2002, Vol. 57 Issue 11, p922 

    Examines the role of opioids in the treatment of severe dyspnoea. Results of a meta-analysis of randomized controlled trials of opioids as treatment for dyspnea; Implications for primary care, secondary care and specialist palliative care; Clinical applications of opioids.

  • COMMENTARY. Robbins, Richard A. // Evidence Based Medicine;May2003, p75 

    The author discusses aspects of drug effectiveness wherein he asserts the beneficial affect of oral or parenteral opioids in relieving dyspnoea in pallative care patients.

  • Review: Oral or parenteral opioids alleviate dyspnea in palliative care. Jennings, A.L.; Davies, A.N.; Higgins, J.P.; Gibbs, J.S.; Broadley, K.E.; Robbins, Richard A. // ACP Journal Club;May/Jun2003, Vol. 138 Issue 3, p72 

    Summarizes a study that investigated whether oral or parenteral opioids are effective in the treatment of dyspnea in palliative care. Sources of the information used in the study; Main results of the study; Nature of opioids.

  • Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Azar, Marc R.; Jones, Byron C.; Schulteis, Gery // Psychopharmacology;2003, Vol. 170 Issue 1, p42 

    Rationale. Conditioned place aversion (CPA) is known to be a sensitive measure of the aversive motivational state produced by opioid withdrawal in rats made chronically dependent on opioids. Objective. The purpose of the present study was to examine the sensitivity of the CPA model in detecting...

  • Review: oral or parenteral opioids alleviate dyspnoea in palliative care. Jennings, A. L.; Davies, A. N.; Higgins, J. P. // Evidence Based Medicine;May2003, p75 

    The article reviews the study "A Systematic Review of the Use of Opioids in the Management of Dyspnoea" by A. L. Jennings and colleagues. It examines the efficacy of oral or parenteral opioids in treating pallative care patients with dyspnoea. It indicates that oral and parenteral opioids can...

  • Prescription drug abuse tied to increased risk of teen suicide.  // Arab American News;8/20/2016, Vol. 32 Issue 1593, p20 

    The article reports on the increase risk of suicide around the world which teens abuse prescription of drugs where some of the used prescription drugs for non-medical purpose.

  • Carbamazepine overdose.  // Reactions Weekly;12/16/2006, Issue 1132, p5 

    This article presents a case study involving a woman who developed increasing drowsiness, coma and subsequent delirium after an overdose of carbamazepine. An hour after ingesting 200 controlled-release tablets of carbamazepine, the woman was brought to an emergency department. She underwent...

  • Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease. Rocker, Graeme; Young, Joanne; Donahue, Margaret; Farquhar, Morag; Simpson, Catherine // CMAJ: Canadian Medical Association Journal;6/12/2012, Vol. 184 Issue 9, pE497 

    Background: A recent national practice guideline recommends the use of opioids for the treatment of refractory dyspnea in patients with advanced chronic obstructive pulmonary disease (COPD). We conducted two qualitative studies to explore the experiences of patients and family caregivers with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics